Singapore markets close in 3 hours 17 minutes

Amoéba S.A. (0RAE.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
0.4500+0.0285 (+6.76%)
At close: 11:07AM BST

Amoéba S.A.

38 Avenue des Frères Montgolfier
Chassieu 69680
France
33 4 26 69 16 00
https://amoeba-nature.com

Sector(s)
Industry
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Fabrice PlassonCo-Founder, CEO & Chairman of the Board395.85kN/A1972
Ms. Valerie FiliatreDeputy CEO & Director147.6kN/A1961
Dr. Sandrine TroussieuxScientific DirectorN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Amoéba S.A. develops biological biocides for the prevention of microbiological risk for water treatment, human wounds, and plant protection. It develops applications by exploiting the characteristics of the amoeba Willaertia magna C2c Maky. The company was incorporated in 2010 and is based in Chassieu, France.

Corporate governance

Amoéba S.A.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.